3 Einträge gefunden

1. Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies

   1. Blauvelt, A
   2. Paul, C
   3. van de Kerkhof, P
   4. Warren, R B
   5. Gottlieb, A B
   6. Langley, R G
   7. Brock, F

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial

   1. Warren, R B
   2. Lebwohl, M
   3. Sofen, H
   4. Piguet, V
   5. Augustin, M
   6. Brock, F
   7. C Arendt,

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2)

   1. Gordon, K B
   2. Warren, R B
   3. Gottlieb, A B
   4. Blauvelt, A
   5. Thaçi, D
   6. Leonardi, C
   7. Poulin, Y

   2021 - Forschungsinformationssystem des UKE - frei zugänglich